Clinical trial
PA.RI.GE. Study. The Prognostic Role of Inflammatory Circulating Biomarkers in HNSCC: a Prospective Multicentric Trial
NCT06809673 is registered in ClinicalTrials.gov with Ospedale Policlinico San Martino as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- PA.RI.GE. Study. The Prognostic Role of Inflammatory Circulating Biomarkers in HNSCC: a Prospective Multicentric Trial
- Lead sponsor
- Ospedale Policlinico San Martino
- Phase
- Observational
- Overall status
- Enrolling by invitation
- Start date
- August 1, 2024
- Completion date
- December 31, 2029
- Enrollment
- 400 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
head and neck cancer